"This is the best use of my time to remain current with what is going on in the industry."
There is increased scrutiny by regulatory agencies on the collection of investigator’s signature as evidence of the overall oversight on the eCRF data reported to the sponsor. Due to different interpretation on the timing and frequency for the collection of the investigator’ssignature, an eCF Task Force has been formed to identify best practices that are based on the compliance to regulatory requirements and on risks such as reputation, credibility, legal liability of the data being used by the sponsor. The intent of this document is to provide a framework for individuals’ risk‐based decisions and best practices for implementing solutions for investigators’ signature collection on data reported to sponsor.
Japanese Translation: eSRA Handbook and Assessment Forms V2026
の日本語版2025.2JP1が2026年6月02日にリリースされました。
eCF Views & News
We send out a brief monthly newsletter via email to all our active eCF members to keep them abreast of the activities of eCF that they can participate in. The more who participate, the better we are "A Network Powered by Peers". Click to see the most current newsletter.
Webinar "AI Validation"
As generative and agentic AI become part of pharmaceutical operations, how do we validate these systems in a practical way? If you are interested in this topic, join our webinar on June 24th 2026!